Unexplained infertility is the diagnosis given when standard fertility testing shows normal results in both partners after at least 12 months of regular unprotected intercourse (or 6 months if the female partner is 36 or older), yet pregnancy has not occurred.^1,2 It accounts for around 15–30% of all infertility cases worldwide and is the most common diagnostic outcome of a complete fertility workup.³

If you have just received this diagnosis, you are not imagining the strange shape of it. You did the tests. The numbers came back fine. And the answer was a kind of non-answer. That experience is the central frustration of unexplained infertility — and the reason it deserves a careful, evidence-based response rather than a shrug.

What Is Unexplained Infertility?

Unexplained infertility is a diagnosis of exclusion. It applies to couples in whom standard investigations — ovulation tracking, hormonal profile, tubal patency, semen analysis, and pelvic imaging — have not identified a specific cause for the difficulty conceiving.^1,2 The 2023 ESHRE guideline defines it as infertility in couples with adequate coital frequency where the female partner is aged 40 or below and has apparently normal ovarian function, fallopian tubes, uterus, cervix, and pelvis, and the male partner has apparently normal testicular function, genitourinary anatomy, and ejaculate.¹

The word unexplained is doing a lot of work here. It does not mean that there is no biological reason. It means that the current standard battery of tests has not detected one. As the European Society of Human Reproduction and Embryology (ESHRE) acknowledges, this category is broad on purpose — it captures couples whose underlying issue may be subtle, multifactorial, or simply beyond the reach of routine clinical testing.¹

Why Do Doctors Diagnose Unexplained Infertility When Tests Are Normal?

Standard fertility testing is designed to detect the most common, treatable causes of infertility — ovulation problems, blocked fallopian tubes, low sperm count, and structural uterine abnormalities. When all of these return normal, the diagnosis defaults to unexplained even though a biological cause almost certainly exists.¹

The standard UK workup recommended by the National Institute for Health and Care Excellence (NICE) includes a serum progesterone test (to confirm ovulation), a semen analysis assessed against World Health Organization (WHO) criteria, a hysterosalpingogram or HyCoSy (to check tubal patency), and a pelvic ultrasound.^2,4 NICE guideline NG257 (published March 2026) replaces the earlier CG156 and lowers the referral threshold for women aged 36 and over, recommending specialist assessment after 6 months of trying rather than 12.²

These tests are excellent at finding the things they are designed to find. They are not designed to assess oocyte chromosomal competence, sperm DNA integrity, endometrial receptivity, subtle endometriosis, or the immune interactions at the implantation site. When one of those factors is the real issue, every standard test can come back normal — which is the awkward middle ground you may now find yourself in.^5,6

What Are the Hidden Causes Standard Tests Might Miss?

Several biological factors can impair conception without showing up on a standard fertility workup. These include oocyte (egg) chromosomal errors, sperm DNA fragmentation, mild endometriosis, suboptimal endometrial receptivity, and inflammatory or immune factors at the uterine lining.^1,5,6

Oocyte quality.

A normal antral follicle count and AMH tell us how many eggs remain, not how many are chromosomally competent. Aneuploidy (an incorrect chromosome number) rises sharply with maternal age, reaching roughly 40% at age 35 and 60% at age 40.⁷ Each mature oocyte also contains 100,000–600,000 mitochondria, and mitochondrial dysfunction is now recognised as central to age-related decline in egg quality.⁸

Sperm DNA integrity.

Standard semen analysis measures concentration, motility, and morphology — but not the integrity of the DNA inside the sperm head. Sperm DNA fragmentation has been linked to lower pregnancy rates and higher miscarriage risk in couples with apparently normal semen parameters.⁹

Subtle endometriosis.

Mild endometriosis can be invisible on ultrasound and only confirmed at laparoscopy, which is not part of routine first-line workup. It is found at meaningful rates in women otherwise labelled unexplained.¹

Endometrial and immune factors.

Implantation depends on a precisely timed window of endometrial receptivity and a tolerant immune environment. Both can be impaired without showing up on a standard ultrasound or hormone panel.⁵

When Should You Seek Help if You Have Unexplained Infertility?

Most national guidelines recommend referral after 12 months of regular unprotected intercourse if the female partner is under 35, or after 6 months if she is 36 or older.^2,3 In the UK, NICE NG257 (March 2026) tightened this threshold by setting earlier specialist referral at age 36, reflecting evidence that delays carry a real cost when ovarian reserve is already declining.²

Earlier referral is also appropriate when there are known risk factors: a history of pelvic infection or surgery, very irregular cycles, prior chemotherapy or radiotherapy, known endometriosis, or a low ovarian reserve test.^2,3 If you are over 40, most clinicians recommend seeking specialist advice within 3 months of starting to try.

Timing matters in unexplained infertility because the diagnosis is partly time-dependent. Many couples with "unexplained" findings will conceive naturally in the following months — but if you are among those who do not, each additional month of delay reduces the chance that fertility treatments will succeed, particularly above age 35.¹⁰

What Treatment Options Work Best for Unexplained Infertility?

The ESHRE 2023 evidence-based guideline recommends intrauterine insemination (IUI) combined with ovarian stimulation as the first-line active treatment for unexplained infertility, with in vitro fertilisation (IVF) reserved for couples who do not conceive after IUI or who have additional prognostic factors.¹ Expectant management remains a valid option for couples with a good natural-conception prognosis.¹¹

A 2019 Cochrane network meta-analysis of interventions for unexplained infertility found insufficient evidence of a live-birth difference between expectant management and any active intervention in the general unexplained population, but it identified that ovarian stimulation with IUI (OS-IUI) and IVF/ICSI may improve live birth rates in couples with a poor natural-conception prognosis.¹¹ That finding is the foundation of the prognosis-based approach now endorsed by ESHRE¹ — and it explains why two couples with the same "unexplained" label can sensibly choose very different next steps.

The table below summarises the main options.

Here is the figure worth holding onto when the treatment ladder feels daunting: a long-term follow-up of the Fast Track and Standard Treatment (FASTT) trial — a randomised study of couples originally diagnosed with unexplained infertility — found that around 93% of women in the cohort eventually had a live birth, by natural conception, fertility treatment, or both. Only 6.6% never achieved a live birth during their reproductive years.¹²

What Lifestyle Changes Can Improve Your Chances Naturally?

Lifestyle factors influence fertility in both partners, and several have been quantified well enough to guide practical decisions. A landmark Nurses' Health Study II analysis found that women who combined five or more low-risk lifestyle factors — healthy weight, regular exercise, no smoking, a Mediterranean-pattern diet, and a daily multivitamin — had a 69% lower risk of ovulatory-disorder infertility than those who combined none.¹³ Lifestyle is not a cure for unexplained infertility, but it is one of the few levers you can pull at home — and the evidence on each piece is worth knowing in detail.

• Body weight. A BMI above 25 is associated with more than a twofold increase in time to pregnancy; a BMI above 35 with more than fourfold.¹⁴ The ASRM 2022 committee opinion on optimising natural fertility recommends weight management as part of preconception care.¹⁵
• Exercise. Thirty to sixty minutes of moderate exercise on most days is associated with fewer ovulatory disorders. Beyond about 60 minutes a day of vigorous exercise, however, the relationship reverses and ovulatory dysfunction risk rises again.¹⁶
• Sleep and stress. Shift work and chronic sleep disturbance are linked to longer time-to-pregnancy in women and a 29% reduction in sperm concentration in men.^17,18 Elevated psychological stress is also associated with longer time-to-pregnancy in the LIFE Study cohort.¹⁹
• Caffeine and alcohol. ASRM 2022 supports keeping caffeine under 200 mg per day (about one to two cups of coffee) and moderate alcohol intake in women trying to conceive.¹⁵ In men, alcohol intake above 14 units per week is linked to reduced semen parameters in a dose-dependent way.²⁰
• Smoking. The ASRM 2018 committee opinion concludes that smoking reduces fertility in both men and women, lowers ovarian reserve, advances menopause, and impairs semen parameters.²¹

The full picture is covered in our deeper guide to a fertility diet.

Which Supplements Have Evidence for Unexplained Infertility?

Several nutrients have evidence relevant to couples with unexplained infertility, but the evidence base sits across a spectrum from well-supported to provisional. Folic acid is well-supported, antioxidants for men show low-to-moderate certainty benefit, omega-3 and CoQ10 show consistent signals, and most other supplements remain adjunctive.^22,23,24,25

Folic acid.

The US Preventive Services Task Force (USPSTF) reaffirmed that all persons planning or capable of pregnancy should take 400–800 mcg of folic acid daily starting at least one month before conception.²² A separate analysis in the BioCycle Study found that women in the highest tertile of synthetic folate intake had a 64% reduction in odds of anovulation compared to the lowest tertile.²⁶

Antioxidants for male subfertility.

A 2022 Cochrane systematic review of 90 RCTs in 10,303 men concluded that antioxidant supplementation may improve semen parameters in subfertile men, with low-to-moderate certainty evidence.²³ A 2024 meta-analysis of nine RCTs in 781 men found that CoQ10 supplementation increased sperm concentration by an average of 10.22 million/mL.²⁴

Antioxidants for female subfertility.

A 2020 Cochrane review of 63 RCTs in 7,760 women found low-certainty evidence with a possible ovulation-improvement signal but insufficient certainty to draw firm conclusions about antioxidant supplementation for female subfertility.²⁵ This is a case where the evidence is suggestive rather than definitive.

CoQ10 for egg quality.

A 2020 meta-analysis of five RCTs in 449 women found that CoQ10 supplementation in women undergoing assisted reproduction was associated with a significantly higher clinical pregnancy rate (28.8% vs 14.1%) compared to controls.²⁷

Omega-3 fatty acids.

A prospective cohort of 900 women aged 30–44 reported that omega-3 supplement users had a fecundability ratio of 1.51 (95% CI 1.12–2.04) compared to non-users — meaning their per-cycle chance of conception was higher.²⁸

Vitamin D.

A small prospective cohort found that clinical pregnancy rates were higher in vitamin-D-sufficient women than in deficient women (67.5% vs 49%).²⁹ Replication in larger trials is still needed before this can be considered first-line evidence.

A balanced way to read this: no supplement is a treatment for unexplained infertility. What several can do, however, is address the kinds of subtle biological factors — oxidative stress, mitochondrial energy, folate status, fatty acid balance — that standard testing does not measure. If supplements are part of your plan, that is the framing worth keeping in mind. See our overview of top fertility supplements for an evidence-ranked list.

What Is the Realistic Prognosis for Unexplained Infertility?

The prognosis for couples diagnosed with unexplained infertility is generally favourable. The FASTT trial long-term follow-up reported that around 93% of women originally diagnosed with unexplained infertility eventually had a live birth, with only 6.6% never achieving one during their reproductive years.¹² Age and duration of infertility are the two strongest prognostic factors.

The 2023 ESHRE guideline and the 2024 Human Reproduction Open prognosis paper both argue that the right next step depends on the couple's individual prognosis rather than a fixed treatment ladder.^1,11 A 32-year-old couple with twelve months of infertility and a healthy lifestyle has a very different outlook from a 39-year-old couple with three years of infertility and one previous IUI failure. The interventions that move the needle differ accordingly.

What this means in practice: an unexplained-infertility diagnosis is not a closed door. It is an invitation to make a deliberate, prognosis-aware decision about the next step — whether that is continued natural conception with optimised lifestyle, an active treatment cycle, or further specialist assessment for the subtle factors standard testing misses.

Frequently Asked Questions

How is unexplained infertility different from primary or secondary infertility?

Primary infertility means no previous pregnancy has occurred. Secondary infertility means a couple has previously conceived but is now struggling. Unexplained infertility is a separate category that describes why a doctor cannot identify the cause — it can be either primary or secondary in pattern.

Can unexplained infertility resolve on its own?

Yes, in many cases. A meaningful proportion of couples with unexplained infertility conceive naturally over the following 12–24 months, particularly when the female partner is under 35 and the duration of infertility is short. This is why expectant management remains a recommended option for good-prognosis couples per the ESHRE 2023 guideline.¹

Should we do IVF straight away if our tests are normal?

Not usually. The ESHRE 2023 guideline recommends IUI with ovarian stimulation as first-line active treatment in most cases, reserving IVF for couples who do not conceive after IUI, those over 38, or those with additional prognostic factors.¹ The decision should be individualised based on prognosis.

Are there additional tests we can ask for?

Yes. Second-line tests sometimes considered include sperm DNA fragmentation, ovarian reserve testing (AMH and antral follicle count), thyroid antibodies, and diagnostic laparoscopy if endometriosis is suspected. These are not routine first-line and are best discussed with a fertility specialist, who can help you decide which (if any) make sense for your situation.

Does diet really make a difference?

Yes — modestly but measurably. The Nurses' Health Study II found that combining five or more low-risk lifestyle factors (including a Mediterranean-pattern diet) was associated with a 69% lower risk of ovulatory-disorder infertility.¹³ Diet will not overcome a structural problem, but it is a meaningful lever in the unexplained-infertility setting.

How long should we try lifestyle changes before considering treatment?

For couples under 35 with a short duration of infertility, three to six months of optimised lifestyle alongside continued conception attempts is a reasonable trial. For couples aged 36 and over, NICE NG257 recommends earlier specialist referral; lifestyle optimisation should happen alongside, not instead of, that assessment.²

Is unexplained infertility caused by stress?

Stress is associated with longer time-to-pregnancy in cohort studies, including the LIFE Study,¹⁹ but the relationship is not causal in the strong sense that resolving stress alone resolves infertility. Managing stress is a reasonable component of a fertility plan, not a treatment by itself.

Supporting Your Fertility with FertilitySmart

A diagnosis of unexplained infertility often makes nutritional support a more meaningful part of the plan, because so many of the subtle factors that standard testing cannot measure — oocyte mitochondrial function, sperm DNA integrity, folate status, fatty acid balance — are nutritionally responsive. Folic acid, CoQ10, omega-3 fatty acids, and a balanced antioxidant intake all have evidence relevant to this clinical picture.

At FertilitySmart, we offer both fertility supplements for women and fertility supplements for men that contain folic acid, CoQ10, vitamin E, zinc, and selenium — nutrients discussed in this guide. Explore our range of evidence-based fertility supplements formulated with the nutrients most relevant to the kinds of biology unexplained infertility involves.

Related Reading

• How to Improve Egg Quality Naturally
  A deep dive on oocyte mitochondrial health, aneuploidy risk by age, and the lifestyle and nutritional levers that support egg quality. Particularly relevant if oocyte factors may be contributing.
• Sperm DNA Fragmentation
  The test that is not part of routine semen analysis but often matters in unexplained infertility. Includes thresholds and modifiable risk factors.
• What Does CoQ10 Do for Fertility?
  The evidence behind CoQ10 for both egg quality and sperm parameters, with dosing context from clinical trials.
• Causes of Secondary Infertility
  A sister article in the Fertility Fundamentals cluster, covering the specific pattern of infertility after a previous pregnancy.
• Fertility and Endometriosis
  Mild endometriosis is one of the conditions standard testing can miss; this article covers diagnosis and management.
• Hypothyroidism and Fertility
  Thyroid dysfunction is sometimes overlooked in routine workups and can present as unexplained infertility.
• Fertility Diet
  The dietary patterns most strongly linked to better fertility outcomes, with specific food groups and meal-planning guidance.
• Top 10 Fertility Supplements
  Evidence-ranked supplements for fertility support, useful for couples building a supplementation plan alongside a clinical pathway.
• Vitamins to Help Get Pregnant
  Focuses on the essential vitamins for conception and early pregnancy, including folate, B12, and vitamin D.
• Trying to Conceive at 35+
  Age-specific guidance for couples in the demographic where NICE NG257 now recommends earlier specialist referral.

References

1. Romualdi D, Ata B, Bhattacharya S, et al. Evidence-based guideline: unexplained infertility. Human Reproduction. 2023;38(10):1881–1890. doi.org/10.1093/humrep/dead150
2. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment (NG257). NICE Guidelines; March 2026.
3. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertility and Sterility. 2020.
4. World Health Organization. WHO laboratory manual for the examination and processing of human semen, 6th edition. WHO; 2021.
5. Quaas A, Dokras A. Diagnosis and treatment of unexplained infertility. Reviews in Obstetrics & Gynecology. 2008;1(2):69–76. pmc.ncbi.nlm.nih.gov/articles/PMC2505167
6. Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reproductive Biology and Endocrinology. 2015;13:37. doi.org/10.1186/s12958-015-0032-1
7. Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies. Fertility and Sterility. 2014;101(3):656–663.
8. May-Panloup P, Boucret L, Chao de la Barca JM, et al. Ovarian ageing: the role of mitochondria in oocytes and follicles. Human Reproduction Update. 2016;22(6):725–743.
9. Esteves SC, Zini A, Coward RM, et al. Sperm DNA fragmentation testing: summary evidence and clinical practice recommendations. Andrologia. 2021;53(2):e13874. doi.org/10.1111/and.13874
10. ASRM Practice Committee. Female age-related fertility decline: a committee opinion. Fertility and Sterility. 2014.
11. Wang R, Danhof NA, Tjon-Kon-Fat RI, et al. Interventions for unexplained infertility: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews. 2019;9:CD012692. doi.org/10.1002/14651858.CD012692.pub2
12. Vaughan DA, Goldman MB, Koniares KG, et al. Long-term reproductive outcomes in patients with unexplained infertility: follow-up of the Fast Track and Standard Treatment Trial participants. Fertility and Sterility. 2022;117(1):193–201. doi:10.1016/j.fertnstert.2021.09.015. pubmed.ncbi.nlm.nih.gov/34620454
13. Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstetrics and Gynecology. 2007;110(5):1050–1058.
14. Hassan MAM, Killick SR. Negative lifestyle is associated with a significant reduction in fecundity. Fertility and Sterility. 2004;81(2):384–392.
15. ASRM Practice Committee. Optimizing natural fertility: a committee opinion. Fertility and Sterility. 2022.
16. Hakimi O, Cameron LC. Effect of exercise on ovulation: a systematic review. Sports Medicine. 2017;47(8):1555–1567.
17. Kloss JD, Perlis ML, Zamzow JA, Culnan EJ, Gracia CR. Sleep, sleep disturbance, and fertility in women. Sleep Medicine Reviews. 2015;22:78–87.
18. Jensen TK, Andersson AM, Skakkebaek NE, et al. Association of sleep disturbances with reduced semen quality: a cross-sectional study among 953 healthy young Danish men. American Journal of Epidemiology. 2013;177(10):1027–1037.
19. Lynch CD, Sundaram R, Maisog JM, Sweeney AM, Buck Louis GM. Preconception stress increases the risk of infertility: results from a couple-based prospective cohort study — the LIFE Study. Human Reproduction. 2014;29(5):1067–1075.
20. Ricci E, Al Beitawi S, Cipriani S, et al. Semen quality and alcohol intake: a systematic review and meta-analysis. Reproductive BioMedicine Online. 2017;34(1):38–47.
21. ASRM Practice Committee. Smoking and infertility: a committee opinion. Fertility and Sterility. 2018.
22. US Preventive Services Task Force. Folic acid supplementation to prevent neural tube defects: USPSTF reaffirmation recommendation statement. JAMA. 2023;330(5):454–459. doi.org/10.1001/jama.2023.12876
23. de Ligny W, Smits RM, Mackenzie-Proctor R, et al. Antioxidants for male subfertility. Cochrane Database of Systematic Reviews. 2022;5:CD007411.
24. Akhigbe RE, et al. CoQ10 supplementation and male fertility: a meta-analysis. Frontiers in Pharmacology. 2024.
25. Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Antioxidants for female subfertility. Cochrane Database of Systematic Reviews. 2020;8:CD007807.
26. Gaskins AJ, Mumford SL, Chavarro JE, et al. Effect of daily fiber and nut intake on reproductive function: the BioCycle Study. PLOS ONE. 2012. doi.org/10.1371/journal.pone.0046276
27. Florou P, Anagnostis P, Theocharis P, Chourdakis M, Goulis DG. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? Journal of Assisted Reproduction and Genetics. 2020;37(10):2377–2387. doi.org/10.1007/s10815-020-01906-3
28. Stanhiser J, Jukic AMZ, Steiner AZ. Omega-3 fatty acid supplementation and fecundability. Human Reproduction. 2022;37(5):1037–1046.
29. Fung JL, Hartman TJ, Schleicher RL, Goldman MB. Association of vitamin D intake and serum levels with fertility. Fertility and Sterility. 2017;108(2):302–311.

Marina Carter

Fertility Health Writer at FertilitySmart

Marina Carter is a specialist health writer with nearly a decade of experience in reproductive health, fertility nutrition, and evidence-based conception support. She has authored over 30 in-depth articles for FertilitySmart, translating peer-reviewed research into clear, practical guidance for individuals and couples on their fertility journey. Read full bio →